High-yield points
- MCAP = mosaic PIK3CA activation: progressive megalencephaly plus capillary malformation or syndactyly. Polymicrogyria is common .
- The Chiari in MCAP is acquired and progressive: the cerebellum outgrows the posterior fossa, in more than half of one longitudinal series .
- Normal earlier imaging does not exclude a new syrinx; re-image with any decline .
- Hydrocephalus: ETV has worked in small series. Shunt when needed .
- Expect vascular bleeding at surgery .
- Alpelisib helps body overgrowth in PROS; its effect on the brain is unproven .
MCAP (formerly "macrocephaly–cutis marmorata telangiectatica congenita") is a brain overgrowth syndrome. It is caused by mostly postzygotic (mosaic) activating mutations in PIK3CA and belongs to the PIK3CA-related overgrowth spectrum (PROS).
It matters to neurosurgeons because the brain, and especially the cerebellum, keeps outgrowing the skull . The result is three linked problems:
- an acquired, progressive Chiari malformation;
- hydrocephalus;
- syringomyelia.
Genetics and definition
- Exome study :
- PIK3CA: 15 mostly postzygotic mutations in 23 individuals with MCAP.
- PIK3R2 and AKT3: caused the related syndrome MPPH (megalencephaly–polymicrogyria–polydactyly–hydrocephalus).
- All three genes are core components of the PI3K–AKT pathway.
- Mosaicism has practical consequences:
- blood testing can be negative;
- testing affected skin (or other affected tissue) raises the yield (see caveats).
- Proposed diagnostic criteria for MCAP :
- progressive megalencephaly; plus
- either vascular anomalies (mainly capillary malformations) or syndactyly.
- Other features:
- polymicrogyria;
- distal limb anomalies;
- connective tissue dysplasia;
- growth dysregulation.
Neuroimaging and natural history
- Longitudinal imaging study (17 patients) :
- More than half developed cerebellar tonsillar herniation with rapid brain growth and progressive posterior fossa crowding in infancy.
- In four, the herniation was confirmed to be acquired.
- At the same time they developed ventriculomegaly (often obstructive), dilated dural venous sinuses and prominent Virchow–Robin spaces.
- Proposed mechanism: a fast-growing cerebellum crowds the posterior fossa, venous congestion follows, CSF absorption suffers, and posterior fossa pressure rises.
- White matter T2 hyperintensities were common.
- Polymicrogyria is the most distinctive cortical malformation . With asymmetric hemispheric overgrowth, it likely drives epilepsy and developmental delay (see caveats).
Neurosurgical problems
- Progressive Chiari and syringomyelia:
- Case 1: a 3-year-old went from no Chiari, to progressive tonsillar herniation, to a holocord syrinx (C2 to the conus) on serial MRI .
- Suboccipital decompression with C1–3 laminectomies helped.
- Bleeding from intracranial vascular malformations complicated the operation.
- Case 2: disproportionate cerebellar growth was documented over 16 years, with a Chiari and syrinx that improved after decompression and duraplasty .
- Lesson: re-image the craniocervical junction and spine when an MCAP patient declines neurologically, even if earlier imaging was normal .
- Hydrocephalus:
- Series of 4 patients :
- 2 were shunted, one needing a revision.
- The 2 treated with endoscopic third ventriculostomy improved without hydrocephalus complications.
- The authors propose ETV as a valid option.
- Choosing treatment: obstruction at the posterior fossa favors ETV or decompression. Communicating hydrocephalus from venous congestion may need a shunt (see caveats).
- Subdural hematomas in infancy have been reported alongside the Chiari .
- Epilepsy:
- polymicrogyria and hemispheric overgrowth can cause drug-resistant epilepsy;
- evaluate as for other malformations of cortical development (see the hemispherectomy and epilepsy-surgery topics).
- Vascular malformations add bleeding risk at surgery . Plan for hemostasis and review vascular imaging beforehand.
Medical therapy
- Alpelisib (BYL719), a PI3Kα inhibitor :
- Patients: 19 with PROS, including CLOVES.
- Result: improved symptoms in all, shrinking vascular tumors and reducing hemihypertrophy and scoliosis, without substantial side effects.
- Not yet proven for the brain: whether it changes brain overgrowth or the Chiari in MCAP is unknown (see caveats).
Surveillance
- Serial brain and spine MRI through infancy and early childhood, when brain growth is fastest :
- posterior fossa crowding;
- tonsillar descent;
- ventricular size;
- syrinx.
- Clinical:
- head circumference;
- development;
- seizures;
- new signs from the brainstem or long tracts.
Related topics
- Chiari I Malformation: syrinx and decompression.
- Endoscopic Third Ventriculostomy: an option for MCAP hydrocephalus.
- Hemimegalencephaly: asymmetric hemispheric overgrowth with epilepsy.
- Epilepsy Surgery in Children: Overview: drug-resistant epilepsy evaluation.
- Cowden Syndrome: another PI3K–AKT–mTOR disorder with macrocephaly.
References
- Rivière JB, Mirzaa GM, O'Roak BJ, et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 2012;44(8):934–940. doi:10.1038/ng.2331. PMID 22729224. verified
- Mirzaa GM, Conway RL, Gripp KW, et al. Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet A 2012;158A(2):269–291. doi:10.1002/ajmg.a.34402. PMID 22228622. verified
- Conway RL, Pressman BD, Dobyns WB, et al. Neuroimaging findings in macrocephaly-capillary malformation: a longitudinal study of 17 patients. Am J Med Genet A 2007;143A(24):2981–3008. doi:10.1002/ajmg.a.32040. PMID 18000912. verified
- Segal D, Heary RF, Sabharwal S, et al. Severe holocord syrinx in a child with megalencephaly-capillary malformation syndrome. J Neurosurg Pediatr 2016;18(1):79–82. doi:10.3171/2016.1.PEDS15482. PMID 27035547. verified
- Deleu T, Jansen K, Calenbergh FV. Brain overgrowth associated with megalencephaly-capillary malformation syndrome causing progressive Chiari and syringomyelia. Surg Neurol Int 2022;13:211. doi:10.25259/SNI_1016_2021. PMID 35673641. verified
- Alamar M, Candela S, Flor-Goikoetxea A, et al. Megalencephaly-capillary malformation syndrome and associated hydrocephalus: treatment options and revision of the literature. Childs Nerv Syst 2021;37(8):2441–2449. doi:10.1007/s00381-021-05222-8. PMID 34047857. verified
- Venot Q, Blanc T, Rabia SH, et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature 2018;558(7711):540–546. doi:10.1038/s41586-018-0217-9. PMID 29899452. verified
Verification (2026-11-17):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed. Numbers were checked against the PubMed abstracts.
Caveats:
- The following are standard practice, not drawn from the cited abstracts:
- testing affected skin to raise the diagnostic yield;
- the choice between ETV and shunt by mechanism;
- epilepsy evaluation;
- the surveillance schedule;
- polymicrogyria and overgrowth as drivers of epilepsy and delay.
- Alpelisib data come from body PROS (including CLOVES), not MCAP brain disease.
- References 4–6 are case reports or small series.
- The figure is an original schematic.